期刊文献+

老年病房2000~2004年铜绿假单胞菌耐药性变迁分析 被引量:5

Analysis on antimicrobial resistance of Pseudomonas aeruginosa during 2000~2004 in the wards for the elderly
下载PDF
导出
摘要 目的监测老年患者医院感染铜绿假单胞菌对13种临床常用抗菌药物耐药性的变化趋势。方法利用全自动微生物鉴定系统VITEK-60对老年病房患者(年龄≥60岁)在2000年1月至2004年12月期间分离的1101株铜绿假单胞菌进行鉴定和体外抗菌药物活性测定。结果铜绿假单胞菌主要从呼吸道标本分离得到,在5202株病原菌中共分离得到1101株铜绿假单胞菌,分离率为21.2%,位居所有病原菌之首。同时,铜绿假单胞菌对13种抗菌药物的敏感性随时间下降。13种常用抗菌药物中,只有妥布霉素、哌拉西林/三唑巴坦、亚胺培南的敏感率大于50%,其中,妥布霉素的敏感性在五年间下降最少,仍保持在80%以上。结论铜绿假单胞菌是老年患者感染的重要病原菌,且耐药程度高,应引起实验室和临床医师高度重视。 Objective To survey the change of antimicrobial resistance of Pseudomonas aeruginosa during 2000- 2004 in the wards for the elderly. Method Antimicrobial susceptibilities of 1101 Pseudomonas aeruginosa were tested by VITEK-60. Result Pseudomonas aeruginosa was the most predominant pathogen. The activity of these 13 antibiotics against Pseudomonas aeruginosa decreased. The susceptibility rates of Pseudomonas aeruginosa to tobramycin piperacillin/tazobactam and imipenem were over 50%. And Tobramycin was the only antibitics whose susceptibility rate unchanged in 5 years. Conclusion Pseudomonas aeruglnosa was an important pathogen in the wards for the elderly. Clinicians should paid more attention on it.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2006年第6期346-348,共3页 Chinese Journal of Antibiotics
关键词 老年患者 铜绿假单胞菌 耐药性 The elderly Pseudomonas aeruginosa Antimicrobial resistance
  • 相关文献

参考文献6

二级参考文献28

  • 1中华人民共和国卫生部医政司.全国临床检验操作规程:第二版[M].南京:东南大学出版社,1995.460.
  • 2Quale J,Landman D,Saurina G, et al. Manipulation of a hospital antimicrobial fomnulary to control an outbreak of vancomycin resistant enterococci. Clin Infect Dis, 1996,23 : 1020.
  • 3Table 2B. Zone Diameter Interpretive Standards and Equivalent Minimal Inhibitory Concentration (MIC) Breakpoints for P. aeruginosa and Acinetobacter spp. Performance standards for antimicrobial susceptibility testing;Ninth informational supplement, M100 -
  • 4Gales AC, Jones RN, Turnidge J, et al. Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns,and molecular typing in the global SENTRY antimicrobial Surveillance Program, 1997- 1999. Clin Infect Dis,2
  • 5Karlowsky JA, Draghi DC, Jones ME, et al. Surveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemothe
  • 6Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug- resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antim
  • 7Karlowsky J A, Kelly LJ, Thornsberry C, et al. Susceptibility to-fluoroquinolones among commonly isolated Gram - negative bacilli in 2000: TRUST and TSN data for the United States. Int J Antimicrob Agents, 2002,19: 21-31.
  • 8Bert F, Maubec E, Bruneau B, et al. Multi - resistant Pseudomonas aeruginosa outbreak associated with contaminated tapwater in a neurosurgery intensive care unit. J Hosp Infect, 1998,39:53- 62.
  • 9Kinska DL, Guilligan PH. Pseudomonas. In: Murray P, ed. Manual of clinical microbiology. Washington, DC: ASM Press, 1999: 517 - 525.
  • 10Pollack M. Pseudomonas aeruginosa. In: Mandell GL, Bennett JE, Dolin R,eds. Principles and practice of infectious diseases. Vol. 2. Philadelphia:Churchill Livingstone,2000:2310 - 2335.

共引文献731

同被引文献21

引证文献5

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部